Personalized healthcare: how to improve outcomes by increasing benefit and decreasing risk through the use of biomarkers.
The use of personalized healthcare is beginning to show promise as a means of increasing benefit and decreasing risk for patients, but much work needs to be done in order to fully exploit the advances in medical science that have occurred over the last 30 years. In particular, molecular approaches that aim to characterize patient individuality must be combined with genetic approaches to capture the promise of this potential revolution in the practice of medicine.
Vargas
Gabriel A
GA
CNS Clinical Biomarker Group, CNS Clinical Research & Exploratory Development, Hoffmann-La Roche, Building 663/2210, 4070 Basel, Switzerland. gabriel.vargas@roche.com